Clinical Trials on Hepadnaviridae-infeksjoner

Total 1625 results

Enyo Pharma
Parexel; Novotech (Australia) Pty Limited; Synteract, Inc.; Eurofins

Terminated

Study of EYP001a to Assess Its Safety and Anti-viral Effect in CHB Patients in Combination With NA (ETV or TD)

Hepatitis B, Chronic

Australia, Hong Kong, Korea, Republic of, Poland
Bausch Health Americas, Inc.

Terminated

Open-label Treatment Extension Study for Patients Who Complete Study RNA200103-201

Hepatitis B, Chronic
Enyo Pharma
CPR Pharma Services Pty Ltd, Australia

Completed

Drug Drug Interaction Study for EYP001 With Entecavir

Hepatitis B, Chronic

Australia
Arbutus Biopharma Corporation

Completed

Study of ARB-001467 in Subjects With Chronic HBV Infection Receiving Nucleos(t)Ide Analogue Therapy

Hepatitis B, Chronic

Australia, New Zealand
Replicor Inc.

Completed

Therapeutic Safety and Efficacy of REP 9AC (REP 2055) in HBV or HCV Infected Patients

Hepatitis B, Chronic

Bangladesh
Nanfang Hospital of Southern Medical University
Novartis; Major Science and Technology Special Project of China Eleventh Five-year

Unknown

EFFORT Extension Study (EFFORT-Ex)

Hepatitis B, Chronic

China
First Affiliated Hospital Xi'an Jiaotong University

Unknown

Study of Antiretroviral Therapy to Prevent HBV Intrauterine Infection

Hepatitis B, Chronic

China
The HIV Netherlands Australia Thailand Research...

Completed

A Study to Test the Efficacy of the HBV Vaccine and to Look at the Prevalence of HBV Infection

Hepatitis b Virus

Thailand
Asian-Pacific Alliance of Liver Disease, Beijing
Beijing Ditan Hospital; National Health and Family Planning Commission, P.R... and other collaborators

Unknown

Emtricitabine for Prevention of Vertical Transmission of HBV in Chinese Pregnant HBsAg Positive Patients

Hepatitis B, Chronic | Pregnancy
Chulalongkorn University

Unknown

Hepatitis B Antigen Kidney Graft Into Protective Level Hepatitis B Antibody Recipients

HBsAg(+) Donor Kidney Allograft | HBsAg(-) Donor Kidney Allograft

Thailand
Enyo Pharma
CPR Pharma Services Pty Ltd, Australia

Completed

Evaluation of the Safety and Pharmacology of EYP001 in HBV Subjects

Hepatitis B, Chronic

Thailand, Netherlands, Australia, Poland
Replicor Inc.

Completed

Therapeutic Safety and Efficacy of REP 2139 (REP 9AC') in HBV Infected Patients

Hepatitis B, Chronic

Bangladesh
Sanjay Gandhi Postgraduate Institute of Medical...

Completed

Entecavir for Decompensated HBV Cirrhosis

Liver Cirrhosis | Hepatitis B

India
Fred Hutchinson Cancer Center
Makerere University; Uganda Cancer Institute

Completed

Strategies for the Prevention of Hepatitis B Among HIV Infected Patients in Uganda

HIV/AIDS and Infections

Uganda
GlaxoSmithKline

Completed

Assess Feasibility of an Acellular Pertussis Vaccine (Pa) Given Soon After Birth, Followed by 3-dose Primary Vaccination With the DTPa-HBV-IPV/Hib Vaccine

Hepatitis B

Germany
Laval University

Recruiting

Immunogenicity of 2 Versus 3 Doses of Combined Hepatitis B Vaccines in 2-18 Months Old Children

Hepatitis B

Canada
Third Affiliated Hospital, Sun Yat-Sen University

Recruiting

Optimized Treatment of Peginterferon Alfa 2a in Treatment Experienced Patients With HBV Related Liver Fibrosis

Hepatitis B | Liver Fibrosis

China
Hospices Civils de Lyon

Recruiting

Creation of a Cohort for the Quantitation and Characterization of Circulating Viral RNAs as a New Biomarker of Hepatitis B Functional Cure. (CirB-RNA)

Hepatitis B

France, Italy
PT Bio Farma

Completed

Safety and Immunogenicity Following Recombinant Hepatitis B (Bio Farma) Vaccine in Adults & Children

Hepatitis B

Indonesia
VBI Vaccines Inc.

Completed

Safety and Immunogenicity of Recombinant Hepatitis B Vaccine Sci-B-Vac® Compared to Engerix-B®

Hepatitis B

Russian Federation
Institut Pasteur

Withdrawn

Neonatal Vaccination Against Hepatitis B in Africa - Sero-survey in Senegal (NeoVac2S)

Hepatitis B
Baylor Research Institute

Completed

Safety and Efficacy of a Hepatitis B Vaccine in Immunosuppressed Patients

Hepatitis B

United States
Mount Sinai Hospital, Canada
University of Toronto

Withdrawn

Combination Hepatitis A and B Vaccine to Induce Immunity in Non-responders

Hepatitis B

Canada
Hasselt University

Unknown

Hepatitis B Prevalence in the Turkish Population Living in Middle Limburg (HBVTR)

Hepatitis B

Belgium
GlaxoSmithKline

Completed

Immuno & Safety Study of GSK Biologicals' Thio or Preservative Free Hepatitis B Vaccine in Subjects Aged 11-15 Yrs

Hepatitis B

Belgium, Ukraine, Australia
Maastricht University Medical Center
CyTuVax

Completed

Safety and Immunogenicity of HBAI20 Hepatitis B Vaccine in Naive Adults and Non-responders

Hepatitis B

Netherlands
GlaxoSmithKline

Completed

Antibody Persistence & Immune Memory in Healthy Adults Previously Vaccinated With Twinrix Adult

Hepatitis B | Hepatitis A

Belgium
GlaxoSmithKline

Completed

Persistence of Immunity Against Hepatitis B in 12-13 Year Old Adolescents After Infant Hepatitis B Vaccination

Hepatitis B

Germany
GlaxoSmithKline

Completed

Long Term Follow-up Study at Years 2, 3, 4 and 5 Where 2 Dosing Schedules of the Combined Hepatitis A and B Vaccine Were Compared

Hepatitis B | Hepatitis A

Australia, Belgium, Spain
GlaxoSmithKline

Completed

Study to Compare the Efficacy of GSK Biologicals' Adjuvants in Combination With the Antigen of the Hepatitis B Vaccine

Hepatitis B

Germany, Belgium
GlaxoSmithKline

Completed

Evaluation of Immune Memory to Twinrix or Comparator by Challenge Dose Administration 4 Years After Primary Vaccination

Hepatitis B | Hepatitis A

Belgium, Czechia
GlaxoSmithKline

Completed

Long-term Immune Persistence of GSK Biologicals' Combined Hepatitis A & B Vaccine Injected According to a 0,1,6 Mth Schedule in Healthy Adults

Hepatitis B | Hepatitis A

Belgium
Merck Sharp & Dohme LLC

Completed

Modified Process Hepatitis B Vaccine in Japanese Young Adults (V232-062)

Hepatitis B
GlaxoSmithKline

Completed

Hepatitis B Antibody Persistence and Immune Response to Hepatitis B Vaccine Challenge in Previously Vaccinated Children

Hepatitis B

Germany
Merck Sharp & Dohme LLC

Completed

A Study of 2 Doses of a Hepatitis B Vaccine (V232 RECOMBIVAX HB) in Healthy Infants (V232-057)

Hepatitis B
Hopital Lariboisière

Completed

Hepatitis B Virus Vertical Transmission From HIV-HBV Co-infected Women

HBV | Vertical Disease Transmission

France
Merck Sharp & Dohme LLC

Completed

Study of Recombinant Modified Process Hepatitis B Vaccine in Older Adults (V232-059)(COMPLETED)

Hepatitis B
GlaxoSmithKline

Completed

Immune Response to Hepatitis B Vaccine Challenge Dose in Subjects Who Received a Primary Neonatal Hepatitis B Vaccine.

Hepatitis B

Thailand
GlaxoSmithKline

Completed

LT F-up Study 16-20 Yrs After Vaccine Dose of Hepatitis B With/Without HBIg in Newborns to HBeAg+ Mothers

Hepatitis B

Thailand
GlaxoSmithKline

Completed

Persistence of Hepatitis B Antibody Levels & Immune Response to a Hepatitis B Vaccine Challenge

Hepatitis B

Germany
Massachusetts General Hospital

Completed

The Effect of Alendronate on the Immune Response to Hepatitis B Vaccine in Healthy Adults

Hepatitis B

United States
GlaxoSmithKline

Completed

Comparison of Monodose and Multidose Presentations of GSK Biologicals' Hepatitis B Vaccine in Terms of Immune Response

Hepatitis B

Belgium
University of Surrey

Completed

A Study to Characterise Immune Responses Following Immunisations With "Fendrix" or "Engerix B" Hepatitis B Vaccines

Hepatitis B

United Kingdom
GlaxoSmithKline

Withdrawn

Evaluation of the Long-term Hepatitis A and B Antibody Persistence in Healthy Adult Subjects, Primed 16 to 20 Years Earlier With GSK Biologicals' Combined Hepatitis A and B Vaccine, Twinrix® (SB208127) in Study HAB-084 (208127/084)

Hepatitis B | Hepatitis A

Czech Republic
GlaxoSmithKline

Completed

Acceptability of Hepatitis B Vaccination in General Population (PopCorn)

Hepatitis B
Beijing Municipal Science & Technology Commission

Unknown

Expression of Th9 Cells and Poor/Non-responsiveness to Hepatitis B Vaccination

Hepatitis B

China
National Taiwan University Hospital
National Science Council, Taiwan

Completed

The Hepatitis B Vaccine Booster Response Among the Youth Who Had Completed Neonatal Hepatitis B Vaccines

Hepatitis B

Taiwan
Henogen
GlaxoSmithKline

Completed

A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Responded to Previous Hepatitis B Vaccination But Lost Antibody.

Hepatitis B

Belgium, Czech Republic, Hungary
Henogen

Completed

Consistency Study of Three Lots of Henogen's Adjuvanted Hepatitis B Vaccine When Given in 0, 1 Month Schedule

Hepatitis B

Czech Republic
GlaxoSmithKline

Completed

Safety, Immunogenicity and Reactogenicity of Recombinant Hepatitis B Vaccine (Adjuvanted & New Formulation) and Engerix™-B

Hepatitis B

Austria

3

Subscribe